A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(7 sites)
United States
VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan Durham VA Medical Center, Durham, NC, Durham, North Carolina VA Portland Health Care System, Portland, OR, Portland, Oregon VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington Age range
18 Years and older
Last updated November 2025